Science384d left

When will the FDA approve Intellia Therapeutics' lonvo-z?

Confidence50%

1% — Unlikely50% — Coin flip99% — Certain

Resolution

Criteria

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.

Source

Kalshi (kalshi.com)

Closes 384d left

Resolves Jan 1, 2028

Created by @dafutr